Blueprint Medicines' Ayvakyt gets approval in EU to treat systemic mastocytosis
26 March 2022 - 1:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Apr 2024 to May 2024
Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From May 2023 to May 2024